DSpace@nitr >
National Institue of Technology- Rourkela >
Conference Papers >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2080/1623

Title: Aspirin Leads Multi Therapeutic Index
Authors: Parida, P
Mishra, S C
Keywords: CAD Modeling
Nanotechnology
Renewable Source of Energy
Issue Date: Jan-2012
Citation: UGC Sponsored National Workshop on Innovative Experiments in Physics, 9-10 January 2012, Neelashaila Mahabidyalaya Rourkela
Abstract: Salicylic acid the main metabolite of aspirin, is an integral part of human and animal metabolism. It was discovered by Arthur Eichengrün, a chemist with the German company Bayer. It is rapidly converted in the body to salicylic acid which is responsible for most of the action as analgesic, anti-inflammatory , Platelet aggregation inhibitor (by inhibiting the production of thromboxane), Anticoagulant. It’s actions are the result of acetylation of certain macromolecules including cycloxygenase. It is one of the oldest analgesic, anti-inflammatory drugs and still widely used. Aspirin is also used long-term, at low doses, to help prevent heart, strokes, and blood clot formation in people at high risk of developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.
Description: Copyright belongs to proceeding Publisher.
URI: http://hdl.handle.net/2080/1623
Appears in Collections:Conference Papers

Files in This Item:

File Description SizeFormat
4. ASPIRIN LEADS MULTI THERAPEUTIC INDEX..pdf28KbAdobe PDFView/Open

Show full item record

All items in DSpace are protected by copyright, with all rights reserved.

 

Powered by DSpace Feedback